Skyline Medical Announces 12 New Trials of the STREAMWAY System
MINNEAPOLIS, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) (NASDAQ:SKLNU) announced today that it has initiated 12 new trials of the STREAMWAY® System in eight different states across the U.S. The trial periods average 2 – 4 weeks …